promotion will not help
a malarial is not the next trendy fashion item
whether a malarial is wanted & successful is decided upon by Big Pharma, big companies & the relevent authorities
CXS is an example of an essential Phase 3 bio-tech. it assisted leukemia & was specifically the only drug available for certain types of leukemia
it was rumoured Big Pharma wanted CXS stopped from serving the conventional lukemea market & only allowed to service a niche market
at Phase 3, the US FDA threw the book at them, not passing Phase 3 because CXS had not developed some diagnostic tool (unrelated to the drug itself)
the share price crashed due to FDA & then it was taken over cheap
SC cannot help, apart from completing the trials
promotion will not help a malarial is not the next trendy...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
